CBFCX
Price
$39.53
Change
-$0.06 (-0.15%)
Updated
Sep 20 closing price
CIREX
Price
$73.17
Change
-$0.08 (-0.11%)
Updated
Sep 20 closing price
Ad is loading...

CBFCX vs CIREX

Header iconCBFCX vs CIREX Comparison
Open Charts CBFCX vs CIREXBanner chart's image
American Funds Global Balanced 529C
Price$39.53
Change-$0.06 (-0.15%)
VolumeN/A
CapitalizationN/A
American Funds Capital Income Bldr 529E
Price$73.17
Change-$0.08 (-0.11%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
CBFCX vs CIREX Comparison Chart
Loading...
VS
CBFCX vs. CIREX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CBFCX is a StrongBuy and CIREX is a Buy.

FUNDAMENTALS
Fundamentals
CIREX has more cash in the bank: 110B vs. CBFCX (27.2B). CIREX pays higher dividends than CBFCX: CIREX (3.02) vs CBFCX (0.83). CBFCX was incepted earlier than CIREX: CBFCX (14 years) vs CIREX (23 years). CIREX is a more actively managed with annual turnover of: 106.00 vs. CBFCX (91.00). CBFCX (250) and CIREX (250) have matching initial minimum investment requirements. CIREX annual gain was more profitable for investors over the last year : 20.94 vs. CBFCX (19.89). CIREX return over 5 years is better than : 39.10 vs. CBFCX (26.19).
CBFCXCIREXCBFCX / CIREX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence14 years23 years-
Gain YTD9.73412.40978%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets27.2B110B25%
Annual Yield % from dividends0.833.0227%
Returns for 1 year19.8920.9495%
Returns for 3 years2.9219.6315%
Returns for 5 years26.1939.1067%
Returns for 10 years37.7367.6256%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PETQ30.75-0.01
-0.03%
PetIQ
GTLB52.02-0.33
-0.63%
GitLab
CCU10.22-0.20
-1.92%
Compania Cervecerias Unidas SA
PTPI0.35-0.02
-6.32%
Petros Pharmaceuticals
TLSA1.02-0.09
-7.81%
Tiziana Life Sciences Ltd